Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 1
R&D Momentum
61/100
Pipeline Velocity
19/100
Trial Completion Rate
86/100
Pipeline Concentration
63/100
Pipeline Freshness
51/100
Strategic Signals
Activity
Last 14 days
Antibiotic Dosing in Pediatric Intensive Care
Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study
Early Model-Informed Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children: Big Solution for Small People?
Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection
TACTIC Study: Tissue Penetration of Antibiotics in CriTically Ill Children
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)